GlassScriptPhysician profile
Carolyn E Rhodes
NPI 1194230490
$3,808.84
in general payments reported to CMS, 2019-2025
22 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 91% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $441 · 2022: $416 · 2023: $842 · 2024: $939 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,687.65 |
| Education | $264.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $990.69 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $752.48 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $432.88 | 2023-2025 | Prolaris |
| Urovant Sciences INC | $228.24 | 2021-2022 | |
| Abbvie INC. | $184.34 | 2022-2025 | |
| Janssen Biotech, INC. | $181.77 | 2022-2025 | Erleada |
| Telix Pharmaceuticals | $175.90 | 2024-2025 | Illuccix |
| Antares Pharma, INC. | $136.27 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Teleflex LLC | $103.32 | 2022-2025 | Barrigel, Urolift |
| Ferring Pharmaceuticals INC. | $98.92 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $93.90 | 2023-2024 | Gentlecath, Gentlecath Glide |
| Tolmar, INC. | $92.20 | 2024-2025 | Eligard, Jatenzo |
| Immunitybio, INC. | $68.71 | 2024-2025 | |
| Olympus America INC. | $61.40 | 2024-2025 | Itind System |
| Medtronic, INC. | $35.68 | 2024 | Interstim |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $31.60 | 2024 | |
| Merck Sharp & Dohme LLC | $29.00 | 2024 | Keytruda |
| Blue Earth Diagnostics | $28.46 | 2024 | |
| Dentsply Ih Ab | $26.26 | 2025 | Lofric |
| Accord Healthcare, INC. | $24.60 | 2024 | |
| Coloplast Corp | $21.82 | 2023 | Speedicath |
| Clarus Therapeutics INC. | $10.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Rhodes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.